Error: Could not add to watchlist. X

BB Adamant Global Biotech

+ Watchlist
ADGLBII:SW
3,883.43
CHF
187.09
4.60%
As of 12:08:00 ET on 07/24/2015.
Fund Type
Open-End Fund
52Wk Range
2,569.63 - 4,161.45
1 Yr Return
49.85%
YTD Return
15.66%
Previous Close
4,070.52
52Wk Range
2,569.63 - 4,161.45
1 Yr Return
49.85%
YTD Return
15.66%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/24/2015)
3,883.43
Total Assets (m CHF) (on 07/24/2015)
167.280
Inception Date
10/15/2010
Last Dividend (on 12/05/2012)
-
Dividend Indicated Gross Yield
-
Fund Managers
JOHN MANIERI
Front Load Fee
1.20%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.20%
Expense Ratio
1.24%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 37.00 k 15.17 m 9.25
Celgene Corp 115.00 k 12.88 m 7.85
Amgen Inc 79.00 k 12.27 m 7.47
Gilead Sciences Inc 120.00 k 11.44 m 6.97
Regeneron Pharmaceuticals Inc 21.00 k 9.21 m 5.61
Alexion Pharmaceuticals Inc 52.00 k 8.75 m 5.33
Kite Pharma Inc 135.00 k 7.56 m 4.61
Vertex Pharmaceuticals Inc 65.00 k 7.45 m 4.54
Illumina Inc 40.00 k 7.21 m 4.39
Isis Pharmaceuticals Inc 115.00 k 7.11 m 4.33
Profile
BB Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050